Bolt Medical

Executive Summary

Bolt Medical is a privately-held medical device company headquartered in Carlsbad, CA, developing a next-generation intravascular lithotripsy (IVL) platform for treating calcified cardiovascular lesions. Unlike conventional balloon-based IVL systems, Bolt's laser-based platform delivers consistent, controlled acoustic energy to fracture calcium, potentially offering advantages in procedural efficiency and patient outcomes. The company has received regulatory approval (likely FDA) for its device, positioning it to compete with established IVL players like Shockwave Medical. Bolt's technology targets a growing market driven by the increasing prevalence of peripheral and coronary artery disease, where effective calcium modification is critical. With an approved product, Bolt Medical is now transitioning to commercial stage. Key near-term milestones include initial hospital adoptions and revenue generation, as well as potential expansion into international markets. The company's laser-based approach could differentiate it in a competitive landscape, though commercial execution and payer adoption remain to be seen. Given the validated IVL market and approval in hand, Bolt Medical presents a potential opportunity for strategic partners or investors seeking exposure to the cardiovascular device space.

Upcoming Catalysts (preview)

• Q3 2026First commercial sales announcements70% success
• Q2 2027CE mark approval for European market entry60% success
• Q4 2026Publication of pivotal clinical data in peer-reviewed journal80% success